Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 28.54
-0.74 (-2.53%)
At close: Mar 6, 2026
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.58 billion as of March 6, 2026. Its market cap has increased by 151.54% in one year.
Market Cap
11.58B
Enterprise Value
11.77B
Revenue
704.16M
Ranking
n/a
PE Ratio
520.83
Stock Price
28.54
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.58B, a decrease of -28.39%. That is a compound annual growth rate of -6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.58B | 12.48% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 13.01B |
| Mabwell (Shanghai) Bioscience | 12.89B |
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |
| InventisBio | 12.37B |
| Staidson (Beijing) BioPharmaceuticals | 12.35B |
| Beijing Hotgen Biotech | 11.90B |
| Hualan Biological Vaccine | 11.55B |
| Chengzhi | 10.85B |